These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 24794676)

  • 1. Using automated text messages to monitor adverse events following immunisation in general practice.
    Leeb A; Regan AK; Peters IJ; Leeb C; Leeb G; Effler PV
    Med J Aust; 2014 Apr; 200(7):416-8. PubMed ID: 24794676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous active surveillance of adverse events following immunisation using SMS technology.
    Westphal DW; Williams SA; Leeb A; Effler PV
    Vaccine; 2016 Jun; 34(29):3350-5. PubMed ID: 27206385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of text-messaging to voice telephone interviews for active surveillance of adverse events following immunisation.
    Regan AK; Blyth CC; Tracey L; Mak DB; Richmond PC; Effler PV
    Vaccine; 2015 Jul; 33(31):3689-94. PubMed ID: 26079616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using SMS to monitor adverse events following trivalent influenza vaccination in pregnant women.
    Regan AK; Blyth CC; Mak DB; Richmond PC; Effler PV
    Aust N Z J Obstet Gynaecol; 2014 Dec; 54(6):522-8. PubMed ID: 25306915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active SMS-based influenza vaccine safety surveillance in Australian children.
    Pillsbury A; Quinn H; Cashman P; Leeb A; Macartney K;
    Vaccine; 2017 Dec; 35(51):7101-7106. PubMed ID: 29128379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and feasibility of SMS m-Health for the detection of adverse events following immunisation (AEFIs) in resource-limited setting-The Zimbabwe stimulated telephone assisted rapid safety surveillance (Zm-STARSS) randomised control trial.
    Nyambayo PPM; Gold MS; Mehta UC; Clarke S; Manyevere R; Chirinda L; Zifamba EN; Nyamandi T
    Vaccine; 2023 Oct; 41(45):6700-6709. PubMed ID: 37805357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of m-Health for the detection of adverse events following immunization - The stimulated telephone assisted rapid safety surveillance (STARSS) randomised control trial.
    Gold MS; Lincoln G; Cashman P; Braunack-Mayer A; Stocks N
    Vaccine; 2021 Jan; 39(2):332-342. PubMed ID: 33279317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active SMS-based surveillance of adverse events following immunisation with influenza and pertussis-containing vaccines in Australian pregnant women using AusVaxSafety.
    Glover C; Crawford N; Leeb A; Wood N; Macartney K
    Vaccine; 2020 Jun; 38(31):4892-4900. PubMed ID: 32499067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smartphone-based active vaccine safety surveillance (SmartVax) at a Swiss adult vaccination clinic - a pilot study.
    Guedel DS; Peters IJ; Banderet F; Epple V; Egli S; Mehling M; Mayr M; Leeb A; Berger CT
    Swiss Med Wkly; 2021 Dec; 151():w30090. PubMed ID: 34908642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allergic adverse events following 2015 seasonal influenza vaccine, Victoria, Australia.
    Clothier HJ; Crawford N; Russell MA; Buttery JP
    Euro Surveill; 2017 May; 22(20):. PubMed ID: 28552101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a text message-based pharmacovigilance tool in Cambodia: pilot study.
    Baron S; Goutard F; Nguon K; Tarantola A
    J Med Internet Res; 2013 Apr; 15(4):e68. PubMed ID: 23591700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Annual report: surveillance of adverse events following immunisation in Australia, 2009.
    Mahajan D; Roomiani I; Gold MS; Lawrence GL; McIntyre PB; Menzies RI
    Commun Dis Intell Q Rep; 2010 Sep; 34(3):259-76. PubMed ID: 21090181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consumer acceptability and validity of m-Health for the detection of adverse events following immunization - The Stimulated Telephone Assisted Rapid Safety Surveillance (STARSS) randomised control trial.
    Gold MS; Lincoln G; Bednarz J; Braunack-Mayer A; Stocks N
    Vaccine; 2021 Jan; 39(2):237-246. PubMed ID: 33309486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multi-site feasibility study to assess fever and wheezing in children after influenza vaccines using text messaging.
    Stockwell MS; Marchant CD; Wodi AP; Barnett ED; Broder KR; Jakob K; Lewis P; Kattan M; Rezendes AM; Barrett A; Sharma D; Fernandez N; LaRussa P
    Vaccine; 2017 Dec; 35(50):6941-6948. PubMed ID: 29089191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaxtracker: Active on-line surveillance for adverse events following inactivated influenza vaccine in children.
    Cashman P; Moberley S; Dalton C; Stephenson J; Elvidge E; Butler M; Durrheim DN
    Vaccine; 2014 Sep; 32(42):5503-8. PubMed ID: 25077424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized Controlled Trial of Text Message Reminders for Increasing Influenza Vaccination.
    Regan AK; Bloomfield L; Peters I; Effler PV
    Ann Fam Med; 2017 Nov; 15(6):507-514. PubMed ID: 29133488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccines safety; effect of supervision or SMS on reporting rates of adverse events following immunization (AEFI) with meningitis vaccine (MenAfriVac™): a randomized controlled trial.
    Ateudjieu J; Stoll B; Nguefack-Tsague G; Tchangou C; Genton B
    Vaccine; 2014 Sep; 32(43):5662-8. PubMed ID: 25160064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Annual report: surveillance of adverse events following immunisation in Australia, 2004.
    Lawrence GL; Boyd I; McIntyre PB; Isaacs D
    Commun Dis Intell Q Rep; 2005; 29(3):248-62. PubMed ID: 16220860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parental views on vaccine safety and future vaccinations of children who experienced an adverse event following routine or seasonal influenza vaccination in 2010.
    Parrella A; Gold M; Marshall H; Braunack-Mayer A; Watson M; Baghurst P
    Hum Vaccin Immunother; 2012 May; 8(5):662-7. PubMed ID: 22634441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Annual report: Surveillance of adverse events following immunisation in Australia, 2005.
    Lawrence G; Boyd I; McIntyre P; Isaacs D
    Commun Dis Intell Q Rep; 2006; 30(3):319-33. PubMed ID: 17120485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.